And, as we discussed in the efficacy section above, 1mg of a sublingual dose is unproven in the scientific literature
Wegovy (Injection) Adults and children age 12 and older with obesity (a body mass index, or BMI, of 30 or higher) Adults and children age 12 and older who are overweight (a BMI of 27 or higher) and have at least one weight-related condition, such as high blood pressure, high cholesterol or triglycerides, or type 2 diabetes Wegovy (Pill) Adults with obesity Adults who are overweight and have at least one weight-related comorbid condition Adults with established heart disease who either have obesity or are overweight Zepbound Adults with obesity Adults who are overweight and have at least one weight-related condition Dosage Weight Loss Other Benefits Beyond weight loss, both medications offer additional health benefits, says Dr
If you plateau at a certain dose, you can escalate further
Measurable weight loss usually starts during weeks two through four
Increased Energy Expenditure Unlike traditional GLP-1 medications, Retatrutide also activates glucagon receptors, which can increase calorie burning and metabolic rate